180 related articles for article (PubMed ID: 32668377)
1. Rapid and simultaneous determination of ten anti-tuberculosis drugs in human plasma by UPLC-MS/MS with applications in therapeutic drug monitoring.
Wang X; Zhang H; Han Y; Huo L; Cao Y; Xu X; Ai L
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122246. PubMed ID: 32668377
[TBL] [Abstract][Full Text] [Related]
2. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
[TBL] [Abstract][Full Text] [Related]
3. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
[TBL] [Abstract][Full Text] [Related]
4. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous determination of the potent anti-tuberculosis regimen-Pyrazinamide, ethambutol, protionamide, clofazimine in beagle dog plasma using LC-MS/MS method coupled with 96-well format plate.
Wu S; Lan L; Jiang J; Ding X; Ho CM; Lou Y; Fan G
J Pharm Biomed Anal; 2019 May; 168():44-54. PubMed ID: 30784889
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
[TBL] [Abstract][Full Text] [Related]
7. Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.
Kim HJ; Seo KA; Kim HM; Jeong ES; Ghim JL; Lee SH; Lee YM; Kim DH; Shin JG
J Pharm Biomed Anal; 2015 Jan; 102():9-16. PubMed ID: 25218029
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection.
Xing Y; Yin L; Le X; Chen J; Zhang L; Li Y; Lu H; Zhang L
Heliyon; 2021 Jul; 7(7):e07532. PubMed ID: 34296020
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study.
Hee KH; Seo JJ; Lee LS
J Pharm Biomed Anal; 2015 Jan; 102():253-60. PubMed ID: 25459921
[TBL] [Abstract][Full Text] [Related]
10. New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS.
Karaźniewicz-Łada M; Kosicka-Noworzyń K; Rao P; Modi N; Xie YL; Heysell SK; Kagan L
J Pharm Biomed Anal; 2023 Oct; 235():115650. PubMed ID: 37597382
[TBL] [Abstract][Full Text] [Related]
11. Rapid and Sensitive LC-MS/MS Method for Simultaneous Determination of Three First-Line Oral Antituberculosis Drug in Plasma.
Han F; Li W; Jin Y; Wang F; Yuan B; Xu H
J Chromatogr Sci; 2021 Apr; 59(5):432-438. PubMed ID: 33434918
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine.
Abouzid M; Kosicka-Noworzyń K; Karaźniewicz-Łada M; Rao P; Modi N; Xie YL; Heysell SK; Główka A; Kagan L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257250
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
Song SH; Jun SH; Park KU; Yoon Y; Lee JH; Kim JQ; Song J
Rapid Commun Mass Spectrom; 2007; 21(7):1331-8. PubMed ID: 17340570
[TBL] [Abstract][Full Text] [Related]
15. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
Mercier T; Desfontaine V; Cruchon S; Da Silva Pereira Clara JA; Briki M; Mazza-Stalder J; Kajkus A; Burger R; Suttels V; Buclin T; Opota O; Koehler N; Sanchez Carballo PM; Lange C; André P; Decosterd LA; Choong E
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123456. PubMed ID: 36240540
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma.
Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Davies Forsman L; Schön T; Bruchfeld J; Alffenaar JC
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122397. PubMed ID: 33091676
[TBL] [Abstract][Full Text] [Related]
17. Simple and sensitive method for the analysis of 14 antituberculosis drugs using liquid chromatography/tandem mass spectrometry in human plasma.
Lei Q; Zhao Y; Wang H; Zhou J; Lv X; Dang L; Zhu C
Rapid Commun Mass Spectrom; 2020 Apr; 34(8):e8667. PubMed ID: 31800129
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Zhou Z; Wu X; Wei Q; Liu Y; Liu P; Ma A; Zou F
Anal Bioanal Chem; 2013 Jul; 405(19):6323-35. PubMed ID: 23719934
[TBL] [Abstract][Full Text] [Related]
19. Development, validation and clinical use of a LC-MS/MS method for the simultaneous determination of the nine main antituberculosis drugs in human plasma.
Fage D; Brilleman R; Deprez G; Payen MC; Cotton F
J Pharm Biomed Anal; 2022 Jun; 215():114776. PubMed ID: 35462286
[TBL] [Abstract][Full Text] [Related]
20. LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
Fachi MM; Vilhena RO; Boger B; Domingos EL; Dos Santos JMMF; Junkert AM; de Fátima Cobre A; Momade DRO; Beraldi-Magalhães F; de Liz MV; Cordeiro-Santos M; Pontarolo R
Biomed Chromatogr; 2020 May; 34(5):e4812. PubMed ID: 32068899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
